Purpose Invasive pulmonary aspergillosis is increasingly reported in patients with influenza
admitted to the intensive care unit (ICU). Classification of patients with influenza-associated …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for develo** invasive fungal infections. Influenza virus is one of the most …

Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or
breakthrough infection, which can become refractory to antifungal treatment and has a high …

Critically ill COVID-19 patients have higher pro-inflammatory (IL-1, IL-2, IL-6, tumor necrosis
alpha) and anti-inflammatory (IL-4, IL-10) cytokine levels, less CD 4 interferon-gamma …

Aspergillosis complicating severe influenza infection has been increasingly detected
worldwide. Recently, coronavirus disease–associated pulmonary aspergillosis (CAPA) has …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Rationale: Whether severe coronavirus disease (COVID-19) is a significant risk factor for the
development of invasive fungal superinfections is of great medical interest and remains, for …

Invasive pulmonary aspergillosis is a complication in critically ill patients with acute
respiratory distress syndrome, especially those with severe influenza pneumonia. We report …

Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …